Puerto Rico vs Tuvalu: The number of people with susceptibility test result for rifampicin
Puerto Rico
14
in 2021
Tuvalu
19
in 2021
Puerto Rico rank
136th
Tuvalu rank
133rd
The number of people with susceptibility test result for rifampicin over time
- Puerto Rico
- Tuvalu
How they compare
Tuvalu currently reports 19 against 14 in Puerto Rico, a difference of 5.
That makes Tuvalu's figure about 1.4 times Puerto Rico's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Puerto Rico ahead.
Puerto Rico ranks 136th and Tuvalu ranks 133rd of 155 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Puerto Rico | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 25.33 | 14 | 11.33 | Puerto Rico |
| 2020s | 18 | 17 | 1 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Puerto Rico or Tuvalu?
- Tuvalu, at 19 against 14 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Puerto Rico and Tuvalu?
- 5, with Tuvalu ahead.
- How many years of comparable data are there for Puerto Rico and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do Puerto Rico and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- Puerto Rico ranks 136th and Tuvalu ranks 133rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.